Lifeboat Foundation

Scientists at Northwestern University say they’ve invented a goo — yes, a goo — that could open the door to regenerating human knee cartilage, a finding that could eventually lead to new clinical ways to rebuild knee joints and avoid invasive and expensive knee replacement surgeries.

Cartilage is the connective tissue that wraps around joints and bones, working to absorb shock, aid mobility, and protect against painful bone-on-bone friction. These are all tough — and important! — jobs, and yet cartilage doesn’t naturally regenerate on its own. As a result, those with worn-down or damaged cartilage often wind up turning to knee replacement surgery. While effective, that road can be expensive and generally requires a lengthy recovery period.

That’s where the goo might come in.

Adeno-associated virus (AAV) has found immense success as a delivery system for gene therapy, yet the small 4.7 kb packaging capacity of the AAV sharply limits the scope of its application. In addition, high doses of AAV are frequently required to facilitate therapeutic effects, leading to acute toxicity issues. While dual and triple AAV approaches have been developed to mitigate the packaging capacity problem, these necessitate even higher doses to ensure that co-infection occurs at sufficient frequency. To address these challenges, we herein describe a novel delivery system consisting of adenovirus (Ad) covalently linked to multiple adeno-associated virus (AAV) capsids as a new way of more efficiently co-infecting cells with lower overall amounts of AAVs. We utilize the DogTag-DogCatcher (DgT-DgC) molecular glue system to construct our AdAAVs and we demonstrate that these hybrid virus complexes achieve enhanced co-transduction of cultured cells. This technology may eventually broaden the utility of AAV gene delivery by providing an alternative to dual or triple AAV which can be employed at lower dose while reaching higher co-transduction efficiency.

Although adeno-associated virus (AAV) gene therapy has shown enormous promise and led to five clinically approved treatments,^1–3 it is consistently hampered by the vector’s low DNA packaging capacity of 4.7 kb. Great effort has gone into developing dual AAV systems, which deliver two parts of a therapeutic gene in separate capsids that aim to co-infect the same cells.^4–7 Analogous triple AAV systems have also been explored.^8,9 Dual and triple AAV systems can recombine their split genes into complete form through mechanisms of DNA trans-splicing, RNA trans-splicing, or protein splicing via split inteins.^5,7 However, dual and triple AAVs typically require higher doses to achieve efficient co-transduction of cells, especially when systemic administration is necessary.¹⁰ This makes sense since the likelihood of two or three cargos reaching the same cell should roughly correspond to the proportion of a single cargo reaching the cell squared or cubed respectively.

A new Nature Human Behaviour study, jointly led by Dr. Margherita Malanchini at Queen Mary University of London and Dr. Andrea Allegrini at University College London, has revealed that non-cognitive skills, such as motivation and self-regulation, are as important as intelligence in determining academic success. These skills become increasingly influential throughout a child’s education, with genetic factors playing a significant role.

The research, conducted in collaboration with an international team of experts, suggests that fostering non-cognitive skills alongside cognitive abilities could significantly improve educational outcomes.

“Our research challenges the long-held assumption that intelligence is the primary driver of academic achievement,” says Dr. Malanchini, Senior Lecturer in Psychology at Queen Mary University of London.

The CDC warned of increasing viral activity on the heels of “unusually high numbers of cases” in Europe earlier this year.

A novel, water-resistant patch-wearable cardioverter-defibrillator (P-WCD) is safe and effective for patients at risk for sudden cardiac arrest, according to a study published in the Aug. 6 issue of the Journal of the American College of Cardiology.

John Hummel, M.D., from The Ohio State University in Columbus, and colleagues assessed the safety and clinical effectiveness of a novel P-WCD. The analysis included 290 patients at risk for sudden cardiac arrest due to ventricular tachycardia/ventricular fibrillation who were not candidates for or refused an implantable defibrillator.

The researchers found that the clinically significant cutaneous adverse device effect rate was 2.30 percent, with no severe adverse effects. There were no device-related deaths or serious adverse events reported. The inappropriate shock rate was 0.36 per 100 patient-months. Nine patients received 11 shocks, of which nine shocks were adjudicated to be appropriate. Eight of nine appropriate shocks were successful with a single shock. Median wear time compliance was 23.5 hours per day.

First patient in UK gets dose of jab designed to kill most common form of lung cancer – and stop it coming back.

Brain-machine interfaces (BMIs) have emerged as a promising solution for restoring communication and control to individuals with severe motor impairments. Traditionally, these systems have been bulky, power-intensive, and limited in their practical applications. Researchers at EPFL have developed the first high-performance, Miniaturized Brain-Machine Interface (MiBMI), offering an extremely small, low-power, highly accurate, and versatile solution.

Published in the latest issue of the IEEE Journal of Solid-State Circuits (“MiBMI: A 192/512-Channel 2.46mm 2 Miniaturized Brain-Machine Interface Chipset Enabling 31-Class Brain-to-Text Conversion Through Distinctive Neural Codes”) and presented at the International Solid-State Circuits Conference, the MiBMI not only enhances the efficiency and scalability of brain-machine interfaces but also paves the way for practical, fully implantable devices. This technology holds the potential to significantly improve the quality of life for patients with conditions such as amyotrophic lateral sclerosis (ALS) and spinal cord injuries.

An image of the chip. (Image: EPFL)

Sensors that can be easily and safely introduced in the brain could have important medical applications and could also contribute to the development of brain-interfacing devices. While significant progress has been made toward the development of these sensors, most existing devices can only be deployed via invasive surgical procedures that can have numerous complications.

Researchers at Seoul National University and other institutes in South Korea recently created a new biodegradable and self-deployable tent electrode that could be far easier to insert onto the surface of the human brain. Their proposed electrode design, outlined in Nature Electronics, could naturally degrade inside the human body without leaving any residues, which means that once it is inserted in the body it does not need to be surgically removed.

“Our recent paper was born out of a growing awareness of the clinical challenges linked to the implantation of electrodes via invasive brain surgery,” Seung-Kyun Kang, corresponding author of the paper, told Medical Xpress.

Noninvasive braincomputer interfaces could vastly improve brain computer control.

Over the past two decades, the international biomedical research community has demonstrated increasingly sophisticated ways to allow a person’s brain to communicate with a device, allowing breakthroughs aimed at improving quality of life, such as access to computers and the internet, and more recently control of a prosthetic limb. DARPA has been at the forefront of this research.

The state of the art in brain-system communications has employed invasive techniques that allow precise, high-quality connections to specific neurons or groups of neurons. These techniques have helped patients with brain injury and other illnesses. However, these techniques are not appropriate for able-bodied people. DARPA now seeks to achieve high levels of brain-system communications without surgery, in its new program, Next-Generation Nonsurgical Neurotechnology (N³).

Continue reading “Nonsurgical Neural Interfaces Could Significantly Expand Use of Neurotechnology” »